Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
Akio Ohta, Michail V. Sitkovsky
Frontiers in Immunology (2014) Vol. 5
Open Access | Times Cited: 272

Showing 1-25 of 272 citing articles:

Purinergic regulation of the immune system
Caglar Cekic, Joel Linden
Nature reviews. Immunology (2016) Vol. 16, Iss. 3, pp. 177-192
Closed Access | Times Cited: 683
Targeting immunosuppressive adenosine in cancer
Dipti Vijayan, Arabella Young, Michele W.L. Teng, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 12, pp. 709-724
Closed Access | Times Cited: 673
Metabolism of immune cells in cancer
Robert D. Leone, Jonathan D. Powell
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 516-531
Open Access | Times Cited: 593
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M. Zarour
Clinical Cancer Research (2016) Vol. 22, Iss. 8, pp. 1856-1864
Open Access | Times Cited: 377
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
Akio Ohta
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 331
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Anliang Xia, Yan Zhang, Xu Jiang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 289
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
Pier Andrea Borea, Stefania Gessi, Stefania Merighi, et al.
Trends in Pharmacological Sciences (2016) Vol. 37, Iss. 6, pp. 419-434
Open Access | Times Cited: 280
FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Reem Saleh, Eyad Elkord
Cancer Letters (2020) Vol. 490, pp. 174-185
Open Access | Times Cited: 247
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
Shohei Koyama, Hiroyoshi Nishikawa
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002591-e002591
Open Access | Times Cited: 214
Role of regulatory T cells in psoriasis pathogenesis and treatment
Lea Nußbaum, You-Yue Chen, Graham S. Ogg
British Journal of Dermatology (2020) Vol. 184, Iss. 1, pp. 14-24
Open Access | Times Cited: 195
The Complex Role of Regulatory T Cells in Immunity and Aging
Lourdes Rocamora‐Reverte, Franz Leonard Melzer, Reinhard Würzner, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 166
Hypoxia Compromises Anti-Cancer Immune Responses
Gabriele Multhoff, Peter Vaupel
Advances in experimental medicine and biology (2019), pp. 131-143
Closed Access | Times Cited: 156
CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint
Miao Yu, Gang Guo, Lei Huang, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 145
Cellular and molecular mechanisms of allergic asthma
Zsolt István Komlósi, Willem van de Veen, Nóra Kovács, et al.
Molecular Aspects of Medicine (2021) Vol. 85, pp. 100995-100995
Open Access | Times Cited: 129
Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
Shuang Liang, Jianjun Yao, Dan Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 123
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 106
Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases
Györgyi Műzes, Ferenc Sípos
Cells (2022) Vol. 11, Iss. 15, pp. 2300-2300
Open Access | Times Cited: 104
Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC
Eric Tu, Kelly McGlinchey, Jixin Wang, et al.
JCI Insight (2022) Vol. 7, Iss. 3
Open Access | Times Cited: 75
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 75
Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia
Anne M. Dickinson, Jean Norden, Shuang Li, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 154
Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options
Derya Kabacaoğlu, Katrin J. Ciecielski, Dietrich Alexander Ruess, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 154
Regulatory T Cells: Molecular Actions on Effector Cells in Immune Regulation
Asiel Arce-Sillas, Diana Denisse Álvarez‐Luquín, Beatriz Tamaya-Domínguez, et al.
Journal of Immunology Research (2016) Vol. 2016, pp. 1-12
Open Access | Times Cited: 128
Expression of CD39 on Activated T Cells Impairs their Survival in Older Individuals
Fengqin Fang, Mingcan Yu, Mary Cavanagh, et al.
Cell Reports (2016) Vol. 14, Iss. 5, pp. 1218-1231
Open Access | Times Cited: 122
Acquisition of new tumor cell properties by MSC-derived exosomes
Yuanyuan Yang, Vesna Bucan, Heike Baehre, et al.
International Journal of Oncology (2015) Vol. 47, Iss. 1, pp. 244-252
Open Access | Times Cited: 115
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang‐Kyou Lee
Immune Network (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 112
Page 1 - Next Page

Scroll to top